Delivery Order SPE2DR25D3111-SPE2DR26FF3JF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,725.17 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with performance in Conshohocken, Pennsylvania and a completion date of November 14, 2025. This non-set-aside, firm fixed price contract was competitively awarded on November 13, 2025, leveraging the company's established capability in federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,697.25 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, effective November 20, 2025, with completion targeted for November 21, 2025. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical will be delivered to the company's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes, with a ceiling value of $3,644.76 and a firm fixed price structure. This is a non-set-aside award representing a competitive procurement action. The order is due for completion by November 5, 2025, with performance to be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,428.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive...
- The Defense Logistics Agency awarded a $16,640.50 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of November 28, 2025. This non-compete, firm fixed-price delivery order was issued on November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a $1,961.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of September 4, 2025. This non-competitive delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,331.42 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.86 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of November 7, 2025. This non-set-aside contract employs firm fixed pricing and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was issued on November 6, 2025, under a competitive procurement process. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,680.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. The award was made on November 25, 2025, with an ultimate completion date of November 26, 2025, under a firm fixed price contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3JFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,276.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on a firm fixed-price basis. The contract, which is non-set-aside and competitively awarded, was issued on November 24, 2025, with an ultimate completion date of November 25, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply support to military healthcare systems globally. The company's federal contract portfolio demonstrates extensive capability in providing vaccines, specialty medications, and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/23/25 |